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For neuronal migration to occur, the cell must undergo morpho-
logical changes that require modifications of the cytoskeleton.
Several different MAPs (microtubule-associated proteins) or ac-
tin-binding proteins are proposed to be involved in the migration
of neurons. Therefore we have specifically analysed how two
members of the MAP family, MAP1B and LIS1 (lissencephaly-
related protein 1), interact with one another and participate in neu-
ronal migration. Our results indicate that, in hippocampal neurons,
MAP1B and LIS1 co-localize, associate and interact with each
another. The interaction between these two MAPs is regulated
by the phosphorylation of MAP1B. Furthermore, this interaction
interferes with the association between LIS1 and the microtubule-
dependent molecular motor, dynein. Clearly, the differential
binding of these cytoskeletal proteins could regulate the functions
attributed to the LIS1–dynein complex, including those related
to extension of the neural processes necessary for neuronal
migration.
Key words: dynein, lissencephaly-related protein 1 (LIS1), micro-
tubule-associated protein 1B (MAP1B), microtubule, migration,
transgenic mouse.
INTRODUCTION
MAP1B (microtubule-associated 1B protein) is the first MAP to
be expressed during the development of the nervous system [1].
Since the expression of this protein is down-regulated during brain
development, MAP1B may play an important role during the mor-
phological differentiation of neurons [2,3]. The results of studies
performed both in the fruitfly [4] and in different loss-of-function
mouse models [5–8] suggest that MAP1B is involved in axonal
growth. Indeed, in one such mouse model, the mice die at a peri-
natal stage [5] and the structural abnormalities observed in all
the laminated brain structures in these mice suggest that MAP1B
could play a role in neuronal migration and axonal guidance [5,9].
Furthermore, the axons of the central nervous system and periph-
eral nervous system neurons derived from a mutant MAP1B mouse
were shorter than WT (wild-type) neurons in culture [10,11].
The biochemical properties and subcellular distribution of
MAP1B are modified by protein phosphorylation [12–14]. How-
ever, little is known about the functional consequences of MAP1B
phosphorylation in neural function.
MAP1B is not the only MAP believed to be involved in neuro-
nal migration. Previously, two other MAPs, DCX (doublecortin)
[15] and LIS1 (lissencephaly-related protein 1) [16,17], were
implicated in neuronal migration. Similarly, deficits in these pro-
teins provoke abnormalities in the migration of neurons into the
embryonic cortex, which, in extreme cases, lead to the loss of
the normal convolutions of the cortex in humans, a disorder known
as lissencephaly (‘smooth brain’).
Lissencephaly is a severe abnormality of neuronal migration
characterized by the absence of (agyria) or a decrease in (pachy-
gyria) the convolutions, resulting in a smooth cerebral cortex
[18]. Furthermore, SBH (subcortical band heterotopia) is a related
disorder in which there are bilateral bands of grey matter inter-
posed in the white matter, between the cortex and the lateral vent-
ricles [19]. SBH is very common among females with mutations
in DCX [15,20]. Indeed, lissencephaly and SBH have been ob-
served in different regions of the same brain, indicating a wide
spectrum of ‘agyria–pachygyria band’.
LIS1 co-immunoprecipitates with the protein dynein, with
which it co-localizes in tissue culture and in the brain [21–23]. In
fact, LIS1 interacts with three distinct subunits of the dynein com-
plex [24]. Overexpression of LIS1 [21–23], as well as impairing
its expression [23,25], interferes with dynein function. In addition,
LIS1 appears to be a regulatory subunit of PAF-AH (platelet-
activating factor acetylhydrolase) 1b [15,26,26a,27]. Cytoplas-
mic dynein is composed of two heavy chains, two or more ICs
(intermediate chains, with a molecular mass of ∼74 kDa), some
LICs (light ICs, with a molecular mass of ∼55 kDa) [28,29]
and several LCs (light chains). These LCs include two copies of
the Tctex1/rp3 LC and a dimer of the highly conserved LC8 pro-
tein [24,30,31]. Furthermore, dynein is capable of forming a com-
plex with dynactin subunits with which LIS1 can also interact [32].
Given that both LIS1 and MAP1B are MAPs that play an impor-
tant role in neuronal migration, it is possible that they interact with
one another. We show that this is indeed the case, and in addition
to examining this novel interaction between MAP1B and LIS1,
we have documented some of the functional consequences with
respect to intracellular localization of the Golgi apparatus [33].
MATERIALS AND METHODS
Animals
Generation, using the gene-trapping approach, of the map1b
mutant used here has been reported previously [34].
Cell cultures
The mouse neuroblastoma cell line N2A was grown in
Dulbecco’s modified Eagle’s medium supplemented with 10%
Abbreviations used: DCX, doublecortin; E18, embryonic day 18; GSK, glycogen synthase kinase; GST, glutathione S-transferase; IC, intermediate
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(v/v) fetal bovine serum, 2 mM glutamine and antibiotics, and
incubated in a humidified atmosphere with 7% CO2.
Hippocampal neurons from E18 (embryonic day 18) embryos
were dissected in Hanks balanced salt solution without calcium
and magnesium (Invitrogen); after treatment with trypsin for
20 min, the cells were gently dissociated, counted and then
seeded in dishes coated with 1 mg/ml poly(L-lysine) and 20 µg/ml
laminin. After culturing in the Neurobasal medium (Invitrogen)
containing 10% (v/v) horse serum for 3 h, the medium was re-
moved and Neurobasal medium containing N2 (Invitrogen) was
added. After 18 h, the cultured cells were fixed in 4% (w/v) para-
formaldehyde and 4% (w/v) sucrose for further processing.
To analyse which kinases might be involved in mode I MAP1B
phosphorylation, the GSK3 (glycogen synthase kinase 3) inhibitor
LiCl (10 mM) or a cdk5 inhibitor roscovitin (200 nM) was added
to the cultures. In other experiments, the phosphatase inhibitor
OA (okadaic acid; 1 µM; mainly inhibiting protein phosphatase
2A) was added to block MAP1B dephosphorylation.
Cell transfection
N2A neuroblastoma cells were transfected with a GSK3 cDNA
[35,36] containing a c-Myc peptide tag. Cells were transfected
with the LipofectamineTM reagent (Invitrogen).
Immunostaining
Cells grown on coverslips were incubated with PBS/0.1% Triton
X-100 for 5 min and then with PBS/5% (w/v) BSA for 1 h.
Subsequently, primary antibodies raised against the following pro-
teins were diluted in PBS/1% BSA and used for labelling the
cells: for LIS1, H-300 antibody diluted 1/100 (Santa Cruz Bio-
technology); for dynein, DIC antibody 1/20 (Sigma); for MAP1B,
N19 antibody 1/20 (Santa Cruz Biotechnology), SMI31 antibody
1/100 (Sternberger Monoclonals; [36,37]) and 125 antibody 1/20
[37] and, as a Golgi marker, LL-FITC antibody 1/2 (Sigma).
The secondary antibodies used were: anti-mouse–Oregon Green
1/200 (Molecular Probes), anti-goat–Texas Red 1/400 (Molecular
Probes) and anti-rabbit–Texas Red 1/400 (Molecular Probes).
All images were captured by either light or confocal laser-
scanning microscopy (Zeiss, Cologne, Germany).
Western-blot analysis
Protein samples were separated on 10% (v/v) acrylamide gel for
dynein, LIS1 and actin and on 6% acrylamide gel for MAP1B.
After electrophoresis, the fractionated proteins were transferred
on to nitrocellulose membranes as indicated previously [5]. The
filters were saturated in a solution containing 5% (w/v) powdered
milk in PBS and incubated with the following antibodies: SMI31
antibody 1/1000, 125 antibody 1/20, N19 antibody 1/1000, anti-
actin antibody 1/1000 (Sigma), anti-LIS1 antibody 1/1000 and
anti-dynein 1/2000. Secondary antibodies (Gibco BRL,
Gaithersburg, MD, U.S.A.) were used at a concentration of 1/2000
and the labelling was visualized using ECL® (PerkinElmer,
Norwalk, CT, U.S.A.).
Polymerization of microtubules
Microtubules were isolated by the method of Shelanski et al. [38]
from the brains of WT or mutant E18 mouse embryos. The isolated
microtubule proteins were characterized by gel electrophoresis.
Immunoprecipitation
A mouse brain (E18) was homogenized in 0.7 ml of cold immuno-
precipitation buffer (1% Triton X-100, 150 mM NaCl, 10 mM
Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA, pH 8.0, 0.2 mM sodium
orthovanadate, 0.2 mM PMSF and 0.5% Nonidet P40). The
homogenate was centrifuged at 16000 g for 15 min at 4 ◦C and the
supernatant was considered as the total cell lysate.
To 400 µg of the supernatant, 5 µg of a specific antibody was
added in a final volume of 1 ml. The solution was vortex-mixed
and incubated for another 1 h at 4 ◦C. Subsequently, 10 µg of
rabbit anti-mouse IgG was added and the mixture was incubated
for a further 30 min at 4 ◦C. Then, 20 µl of 50% Protein A–aga-
rose bead solution was added, mixed and incubated with agitation
for 30 min at 4 ◦C. The beads were pelleted by centrifugation at
16000 g for 15 min at 4 ◦C, and the supernatant was removed. The
pellet was washed twice with the immunoprecipitation buffer and
resuspended in 30 µl of 2× concentrated electrophoresis sample
buffer [250 mM Tris, pH 6.8, 4% (w/v) SDS, 10% glycerol,
0.006% Bromophenol Blue and 2% (w/v) 2-mercaptoethanol].
The proteins were separated by gel electrophoresis, and the
fractionated proteins were then characterized by Western-blot
analysis.
Pull-down assay
DNAs encoding GST (glutathione S-transferase) and GST–LIS1
recombinant proteins were inserted into the pGEX-4T plasmid
(Amersham Biosciences) and the proteins were expressed in
Escherichia coli BL21 cells. Transformed cells were cultured in
SOC medium (20 g/l Bacto Tryptone, 5 g/l Bacto yeast extract,
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4 and
20 mM glucose) and recombinant protein expression was induced
by the addition of 0.1 mM isopropyl β-D-thiogalactoside for 2 h at
30 ◦C. The cell lysates were centrifuged and the supernatant was
then incubated with glutathione–Sepharose 4B beads (Amersham
Biosciences) for 2 h at room temperature (22 ◦C). This mixture
was then incubated with brain extracts prepared in a buffer con-
taining 20 mM Tris/HCl (pH 6.8), 100 mM NaCl, 1 mM EDTA,
0.1% Triton X-100 and protease inhibitors. Afterwards, the
proteins bound to glutathione–Sepharose beads were washed four
times and then resuspended in 2× electrophoresis sample buffer,
boiled and separated by gel electrophoresis.
Cross-linking assays
Protein (200 µg) from soluble E18 brain extracts was incubated
with increasing concentrations of formaldehyde (0, 0.01% and
0.1%) for 30 min at room temperature. The reaction was stopped
by adding 1% glycine and the electrophoresis sample buffer.
The mixture was boiled for 5 min at 90 ◦C, and the proteins were
characterized by electrophoresis and Western blotting.
RESULTS
LIS1 interacts with MAP1B
Given the important role of LIS1 in the development of the brain,
we were interested in testing the hypothesis that the interaction of
LIS1 with other MAPs can affect neuronal migration. Therefore
we initially focused our attention on the possible interaction
between LIS1 and MAP1B. To address this, we analysed the rela-
tionship between these proteins using a MAP1B-deficient trans-
genic mouse, performing our experiments during the late-prenatal
stage of the development of the nervous system (E17–E18).
The possibility that LIS1 and MAP1B might interact was exa-
mined using several biochemical assays. Thus we found that
GST–LIS1 was capable of pulling down MAP1B from an extract
isolated from E18 mouse brains, but no proteins associated with
GST alone (Figure 1A). These results were further confirmed in
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Figure 1 MAP1B interacts with LIS1
(A) Proteins from brain extracts were pulled down using GST–LIS1. (a) GST and GST–LIS1
were expressed and characterized (see the Materials and methods section). (b) MAP1B is
specifically pulled-down with GST–LIS1; (c) the control of LIS1 is shown. The electrophoretic
mobilities of the 200, 70, 45 and 30 kDa markers are indicated. (B) MAP1B and LIS1
proteins co-immunoprecipitate. Upper panel: immunoprecipitation experiments performed with
antibodies raised against MAP1B (IPP MAP1B) or LIS1 (IPP LIS1), and proteins were visualized
by Western blot (WB) with anti-MAP1B antibody. Lower panel: a similar experiment was con-
ducted but the proteins were visualized with an anti-LIS1 antibody. The total protein (T) before
immunoprecipitation and the immunoprecipitated (P) and non-immunoprecipitated (S) proteins
are indicated. (C) To analyse the specificity of the interaction described in (A, B), a pellet
fraction obtained after immunoprecipitation with MAP1B and LIS1 antibodies was revealed
using antibodies against MAP2 and DCX. (D) The interaction between LIS1 and MAP1B is
also specific when compared with mDab, a protein involved in the reelin signalling pathway.
Molecular mass (kDa) is indicated on the right.
co-immunoprecipitation assays, where antibodies raised against
MAP1B but not the preimmune serum were capable of co-
immunoprecipitating LIS1 as well as MAP1B itself (Figure 1B,
upper panel). Likewise, antibodies against LIS1 specifically co-
precipitated MAP1B (Figure 1B, lower panel). The specificity
of this interaction was demonstrated by the failure to detect an
interaction between MAP1B and other neuronal MAPs, such as
MAP2 and DCX (Figure 1C). DCX and phosphorylated mDab1
Figure 2 Cross-linking of MAP1B with LIS1
Protein from a mouse brain extract was incubated for 30 min at room temperature in the presence
or absence of formaldehyde (FA). After this incubation, the protein was separated by gel
electrophoresis and characterized by Western blotting (WB) using an antibody raised against
MAP1B or LIS1. Additionally, the amount of actin in each sample was determined by dot blot
(DB). The electrophoretic mobilities for MAP1B and LIS1 as well as the 200 and 40 kDa markers
are indicated.
did co-precipitate with LIS1, as described elsewhere (Figures 1C
and 1D; [39,40]); however, MAP1B did not appear to interact with
mDab1 (Figure 1D). These results indicate that MAP1B interacts
specifically with LIS1.
To determine whether this interaction between LIS1 and
MAP1B was direct or whether it required another molecule, we
performed cross-linking experiments (Figure 2). In the presence
of formaldehyde, a protein complex with electrophoretic mobility
lower than that of MAP1B was observed. This protein complex
was recognized by antibodies raised against MAP1B and LIS1,
indicating that both proteins are present in the complex and sug-
gesting that the complex is formed by the direct binding between
the two proteins.
LIS1–MAP1B interaction is regulated by MAP1B phosphorylation
MAP1B is a phosphoprotein [14] and this transient post-trans-
lational modification plays an important role in its regulation.
Therefore we tested whether MAP1B phosphorylation influences
its interaction with LIS1. MAP1B phosphorylation can be classi-
fied into two modes. Mode I phosphorylation involves proline-
directed protein kinases, whereas mode II phosphorylation is
dependent on the kinase CK2 [12,14,37]. These different modes
of phosphorylation can be distinguished by the use of two dif-
ferent phospho-specific antibodies (SMI31 and 125 antibodies).
Mode I phosphorylation occurs mainly due to modification of
MAP1B by GSK3 [13,14] and it can be detected by the reaction
of phospho-MAP1B with the antibody SMI31. Mode II phos-
phorylation can be detected using the antibody 125 [14,41].
When proteins were immunoprecipitated with an antibody
raised against LIS1, only mode II-phosphorylated MAP1B was
seen to associate with LIS1 (Figure 3A). These results were in
sharp contrast with those observed when the N19 antibody, which
does not recognize phosphorylated MAP1B, was used. These re-
sults were further substantiated by immunocytochemistry. A high
degree of co-localization was observed between mode II-phos-
phorylated MAP1B and LIS1 (Figure 3B), whereas mode I-
phosphorylated MAP1B and LIS1 only weakly co-localized (Fig-
ure 3B). Whereas mode I phospho-MAP1B is mainly located in
the distal axonal region, mode II phospho-MAP1B (that inter-
acts with LIS1) is found in the proximal axonal and somatoden-
dritic regions (Figure 3B). The results of these experiments
strongly suggest that MAP1B and LIS1 interact and that this inter-
action is disturbed by mode I MAP1B phosphorylation.
c© 2005 Biochemical Society
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Figure 3 The interaction between MAP1B and LIS1 is regulated by MAP1B phosphorylation
(A) Immunoprecipitation of brain extracts with LIS1 was performed using specific antibodies and the phosphorylated MAP1B was analysed. The MAP1B recovered in the pellet fraction was rich in
mode II-phosphorylated MAP1B, whereas mode I-phosphorylated MAP1B was recovered mostly in the supernatant fraction. (B) Double immunofluorescence of hippocampal neurons in culture,
showing the distribution of LIS1 and mode I-phosphorylated MAP1B or mode II-phosphorylated MAP1B. (C) Immunoprecipitation with A6 (an antibody that recognizes MAP1B irrespective of its
level of phosphorylation). The precipitated proteins were fractionated by gel electrophoresis and visualized with an antibody raised against LIS1. The immunoprecipitated proteins from cultured
neurons incubated in the presence of lithium (a specific inhibitor of mode I MAP1B phophorylation) or in the presence of OA (which prevents the dephosphorylation of MAP1B phosphorylated by
mode I) are shown, together with those from untreated cells (control, C).
In support of this conclusion, we found that the presence of
lithium, an inhibitor of GSK3 and mode I MAP1B phosphoryl-
ations, augmented the association between MAP1B and LIS1 ob-
served by immunoprecipitation (Figure 3C). However, no differ-
ences were detected after treatment with roscovitin, an inhibitor
of another proline-directed kinase, cdk5 (results not shown). Fur-
thermore, the interaction between MAP1B and LIS1 was impaired
in the presence of OA that blocks MAP1B mode I dephosphoryl-
ation (Figure 3C).
To investigate further how mode I phosphorylation of MAP1B
may affect its binding to LIS1, we augmented the phosphorylation
of MAP1B by expressing GSK3 in the neuroblastoma N2A cells
containing MAP1B and LIS1, and transfecting these cells with
GSK3β cDNA. A high proportion of N2A cells were transfected,
as seen by the expression of the Myc label co-expressed with
GSK3β; upon GSK3 expression, mode I phosphorylation of
MAP1B increased (Figures 4A and 4B). As a consequence
of MAP1B hyperphosphorylation, less phospho-MAP1B co-
immunoprecipitated with LIS1 (Figure 4C).
Dynein does not bind to MAP1B
LIS1 has been shown to interact with the cytoplasmic motor pro-
tein dynein [21,23,25]. It is known that the dynein–LIS1 connec-
tion is conserved in yeast, fungi, flies and mammals, and hence it
is possible that dynein interacts with MAP1B. Dynein was visual-
ized with a serum that recognizes its LICs, but these two dynein
proteins did not co-immunoprecipitate with MAP1B antibodies
(Figure 5A). In addition, immunocytochemistry demonstrated that
the two proteins did not co-localize. Staining for dynein revealed a
punctate pattern proximal to the soma with no significant overlap
with MAP1B staining (Figure 5B). These results suggest that
MAP1B does not bind to dynein.
Absence of MAP1B can modify the LIS1–dynein interaction
Since LIS1 interacts with both MAP1B and dynein [32], we have
tested whether decreasing the amount of MAP1B available will
affect the interaction between LIS1 and dynein. The overall levels
of LIS1 or dynein in the presence or absence of MAP1B were
initially established by comparing the amounts of protein in brain
extracts obtained from WT and from MAP1B-deficient mice [KO
(knockout) mice]. No differences were observed in the amount of
LIS1 or dynein on comparing WT and KO mice (Figure 6A).
To test whether the absence of MAP1B affects the association
between LIS1 and dynein, GST–LIS1 was used to recover dynein
from the brain cell extracts derived from mice lacking MAP1B [5].
The amounts of dynein recovered in this way were compared with
that bound by GST–LIS1 in brain extracts from WT littermates.
In the absence of MAP1B, more dynein was associated with
LIS1 (Figure 6Ba), and when this increase was quantified, in the
absence of MAP1B, the interaction between dynein and LIS1 was
augmented by 3–4-fold (Figure 6Bb).
These results suggest that MAP1B and dynein proteins may
compete for LIS1 and, to test this possibility, brain extracts from
MAP1B-deficient or WT mice were immunoprecipitated with
an antibody raised against LIS1. The proportion of dynein that
co-immunoprecipitated with LIS1 was compared in control and
MAP1B-deficient brains. As shown previously, in the absence
of MAP1B, the association of LIC dynein with LIS1 increased.
c© 2005 Biochemical Society
MAP1B can modify the LIS1–dynein interaction 337
Figure 4 GSK3 regulates the interaction of MAP1B with LIS1
(A) N2A neuroblastoma cells were transfected with DNA encoding GSK3β bearing a c-Myc peptide tag. The amounts of LIS1, MAP1B, c-Myc, total GSK3, mode I-phosphorylated MAP1B (MAP1B-P)
and actin were measured in untransfected (C) and GSK3-transfected cells. (B) The proportion of transfected cells was measured using the reaction with an antibody raised against the c-Myc
peptide. (C) A protein extract from untransfected cells (C) or transfected (GSK3) cells was immunoprecipitated (IPP) with an antibody raised against LIS1, and the presence of MAP1B or LIS1 in the
immunoprecipitated (P) or soluble (S) fraction was determined by Western blotting.
When we estimated the amount of individual LICs of dynein (1
and 2) that had interacted with LIS1, significant changes were
observed in both proteins between control and MAP1B-deficient
extracts (Figure 6C). Our results strongly suggest that MAP1B
competes with dynein for LIS1 binding and that the presence
of MAP1B could interfere with the subunit composition of the
dynein complex.
Association of LIS1 with microtubules in the presence
or absence of MAP1B
On the basis of these results, we examined the co-polymerization
of LIS1 with microtubules in the presence or absence of MAP1B.
We found that, in the presence of MAP1B, more LIS1 was bound
to microtubules (Figure 7). This is highly suggestive that LIS1
can bind to microtubules not only through a direct association
with tubulin, but also through its interaction with MAP1B.
The lack of MAP1B may affect the function of the
LIS1–dynein complex
The localization and organization of the Golgi complex is depen-
dent on microtubule assembly. In the absence of polymerized
microtubules, the Golgi apparatus becomes dispersed [42] and
it has been suggested [33] that the dynein–LIS1 complex could
play an important role in maintaining the Golgi apparatus close to
the cell nucleus [29]. Since the presence of MAP1B appears
to affect the dynein–LIS1 complex, the localization of the Golgi
apparatus was analysed in hippocampal neurons containing or
lacking MAP1B. In WT neurons (Figure 8A), the Golgi apparatus
is located close to the nucleus and the microtubule-organizing
centre, whereas in neurons lacking MAP1B, the Golgi apparatus
is much more dispersed (Figure 8B).
We also examined whether there were differences in the micro-
tubule network in neurons from MAP1B–/– and WT mice. We
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Figure 5 Dynein does not bind to MAP1B
(A) Protein from mouse brain extracts was immunoprecipitated (IP) with antibodies raised against LIC dynein or MAP1B, and then visualized with an anti-LIC dynein antibody. (B) Double
immunofluorescence analysed by confocal microscopy, showing the distribution of dynein, of mode II-phosphorylated MAP1B and the merged image.
Figure 6 The absence of MAP1B does not affect the overall levels of dynein or LIS1 proteins, but results in an increase in LIS1–dynein interaction
(A) Western-blot analyses of brain extracts derived from control (WT) and MAP1B-deficient (KO) mice are shown. Actin was tested as a loading control. (B, a) These experiments are similar to the
pull-down experiments indicated in Figure 1(A) using GST–LIS1 recombinant protein mixed with brain extracts from control (WT) and from MAP1B-deficient (KO) animals. The first panel shows that
MAP1B was recovered from the WT brain extracts after pull down with GST–LIS1, whereas no MAP1B was recovered from KO mice brain extracts. An increase in the amount of dynein subunits recovered
after GST–LIS1 pull down was observed when the proteins were mixed with KO mice brain extracts. No MAP2 was recovered after pull down. Tubulin was used as an internal control to compare
the protein concentration in the two brain extracts. (B, b) Quantification of the proteins recovered after pull-down experiments. (C, a) Co-immunoprecipitation experiments show that dynein LICs
bind to LIS1 in the presence (WT) or absence (KO) of MAP1B. In the absence of MAP1B, a decrease of protein 1 was detected as well as an increase of protein 2, corresponding to the dynein
LICs. (C, b) Quantification of the results by densitometry analysis.
focused our attention on the axonal growth cones where micro-
tubules could be detected. Differences were indeed detected in
the organization of the microtubule network between WT and
MAP1B–/– neurons (Figure 9). The loss of MAP1B caused
a decrease in the proportion of microtubules present in the
peripheral growth cone region when compared with that observed
in WT cells. This observation is also in accordance with previous
results [10,11].
DISCUSSION
The interaction between MAP1B and LIS1 is dependent
on phosphorylation
It has been shown previously that LIS1 interacts with the MAP
CLIP170 [43], a MAP that binds mainly to the growing tips of
microtubules [44]. In the present study, we have shown that LIS1
can also interact with another MAP, MAP1B. Interestingly, this
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Figure 7 Association of LIS1 with neuronal microtubules in the presence
or absence of MAP1B
Microtubule protein was polymerized in vitro and the association of LIS1 with the polymers was
examined. The first panel shows that MAP1B was present in the microtubule fraction derived
from control animals (WT) but was absent from those from mutant animals (KO). Furthermore,
LIS1 was enriched in the pellet fraction after microtubule polymerization. The level of assembled
tubulin is also shown. A decrease (30 %) in the amount of LIS1 bound to microtubules was
found in the KO-derived polymer compared with that found in microtubules from WT mice.
interaction is negatively regulated by phosphorylation of MAP1B
(mode I) and, in fact, this is the third interaction involving LIS1
that is sensitive to phosphorylation. Whereas the interaction
between LIS1 and CLIP170 is sensitive to the status of LIS1 phos-
phorylation [43], the interaction between LIS1 and mDab1 is
regulated by mDab1 phosphorylation [40]. We show here that the
interaction between LIS1 and MAP1B is regulated by MAP1B
Figure 9 Microtubule network in growth cones in the presence or absence
of MAP1B
(A) Hippocampal neurons from WT or KO mice were cultured, and the presence of microtubules
in their growth cones was studied by immunofluorescence analysis using an antibody raised
against Tyr-tubulin. A difference in the amounts of peripheral microtubules was found. Scale
bars, 5 µm. The outline of the growth cones is indicated in each case by white dots. (B) Same
as (A), but the growth cones were analysed by immunofluorescence using phalloidin to identify
their shape.
Figure 8 Golgi localization in neurons with or without MAP1B
Hippocampal neurons at culture stage 2 (see [5]) from WT (A) or mutant MAP1B (B) mice were incubated with the antibody LL-FITC to localize the Golgi complex (see the Material and methods
section). In neurons from WT mice, it is localized to a specific site close to the nucleus, whereas it appears to be dispersed in neurons lacking MAP1B. Scale bars, 50 µm.
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phosphorylation and this could have important functional conse-
quences, especially if we bear in mind that the protein reelin regu-
lates mDab phosphorylation. Reelin plays a key role in cerebral
cortex lamination, and signalling through this protein is respon-
sible for the tyrosine phosphorylation of the adaptor protein
mDab1 [40]. Thus, based on the results presented here, we sug-
gest that reelin could influence the LIS1–dynein interaction
through mDab1 phosphorylation and through MAP1B mode I
phosphorylation that will intensify this interaction.
MAP1B–LIS1 versus dynein–LIS1
MAP1B could compete with dynein for binding to LIS1 since it is
known that LIS1 can interact with dynein ICs in non-mammalian
and mammalian cells [21,23]. We have now found that, upon bind-
ing to LIS1, MAP1B may modify the proportions of specific LIC
dynein subunits bound to LIS1. We also found that these dynein
proteins bind differently to LIS1 depending on whether MAP1B
is present or not. On the other hand, LIS1 binding to microtubules
also seems to be affected by the presence of MAP1B. In MAP1B-
deficient cells, there is a shift in the proportion of LIS1 found in the
soluble and pelleted fractions after microtubule polymerization.
Therefore a consequence of the loss of MAP1B function will be
to promote the LIS1–dynein interaction.
Cytoplasmic dynein is important for the organization of the
Golgi apparatus [33] and for cell migration. In this context, modi-
fication of the neuronal cytoskeleton could have a key role in
generating the correct movement of neurons [45].
MAP1B and dynein compete for LIS1
MAP1B is involved in neuronal outgrowth [10,30] and recently
it has been reported that MAP1B could play a role in neuronal
migration, depending on the presence of Netrin-1 [46] or that of
reelin [14]. Therefore it is interesting that MAP1B binds to LIS1,
another MAP involved in neuronal migration, as discussed above.
On the other hand, the novel LIS1–MAP1B interaction descri-
bed in the present study, and specifically the competition between
MAP1B and dynein to associate with LIS1, could be another of
several control points at which LIS1 and/or dynein influences
neuronal migration. This concept is reinforced by the fact that, in
the absence of MAP1B, the LIS1–dynein interaction is altered.
One explanation for such a behaviour could be related to the fact
that the microtubule-binding domain of dynein is composed of
at least three different sequences in the central domain of the
protein. Two of these sequences are highly similar to the micro-
tubule-binding domain of MAP1B [47]. Additionally, the peptides
that displace MAP1B binding from microtubules are also capable
of interfering with the dynein–microtubule interaction [47].
Taking into account all these results, we hypothesize that these
proteins, MAP1B and dynein, compete for the same microtubule-
binding site [47].
It will be of interest to determine the effects of depleting
MAP1B on the function of the LIS1–dynein complex, since it
could affect axonal transport. Future experiments will address the
possible role of MAP1B in the impairment of axonal transport
regulated by dynein.
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